The main research product of Enthea so far is a cost-effectiveness analysis of drug liberalization as a mental health intervention.
We've taken a look at the potential of psychedelic therapy as an addiction treatment.
We have also prepared a summary & analysis of the full text of the Oregon 2020 ballot initiative to legalize therapeutic psilocybin.
Our research products:
And there's more research on our blog, including commentaries on recently published psychedelic papers!
Our summary of Carhart-Harris & Friston's REBUS paper is a reader favorite.